Hyperoxia exaggerates bacterial dissemination and lethality in Pseudomonas aeruginosa pneumonia

Pulm Pharmacol Ther. 2009 Aug;22(4):333-9. doi: 10.1016/j.pupt.2008.12.021. Epub 2009 Jan 8.

Abstract

Effects of hyperoxia on lethality in mice with Pseudomonas aeruginosa pneumonia were defined, and protective roles of macrolides were examined both in vitro and in vivo. Sub-lethal hyperoxia accelerated lethality of mice with P. aeruginosa pneumonia. Bacterial number was not different in the lungs, but higher in the liver of mice in hyperoxic conditions. Filter-sterilized culture supernatants of bacteria induced loss of viability of alveolar epithelial cells, which was exaggerated in hyperoxia. Metalloprotease blocking by inhibitor or gene-disruption in bacteria resulted in partial reduction of cytotoxic activity in culture supernatants. Co-culture of bacteria with sub-inhibitory concentrations of macrolides, such as azithromycin, reduced cytotoxic activity in the culture supernatants. Azithromycin provided significant survival benefit in hyperoxia-pneumonia model, which was associated with suppression of bacterial dissemination to extra-pulmonary organs. These results suggest that hyperoxia serves as an important cofactor for bacterial dissemination and lethality of P. aeruginosa pneumonia. Our data identify the potential of macrolides to protect individuals with P. aeruginosa pneumonia in the setting of hyperoxia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / therapeutic use*
  • Azithromycin / therapeutic use
  • Caspase 3 / metabolism
  • Cell Line
  • Cell Survival / drug effects
  • Female
  • Gene Deletion
  • Histones / metabolism
  • Humans
  • Hyperoxia / microbiology*
  • Liver / microbiology
  • Lung / microbiology
  • Macrolides / therapeutic use
  • Mice
  • Mice, Inbred BALB C
  • Oxygen / toxicity
  • Pneumonia, Bacterial / microbiology*
  • Pneumonia, Bacterial / mortality
  • Protease Inhibitors / pharmacology
  • Pseudomonas Infections / microbiology*
  • Pseudomonas Infections / mortality
  • Pseudomonas aeruginosa / genetics*
  • Pseudomonas aeruginosa / pathogenicity*
  • Virulence Factors / biosynthesis
  • Virulence Factors / genetics

Substances

  • Anti-Bacterial Agents
  • Histones
  • Macrolides
  • Protease Inhibitors
  • Virulence Factors
  • Azithromycin
  • Caspase 3
  • Oxygen